SCHEMBL10067692

SCHEMBL10067692

CC(=O)OC(c1ccc(C(=O)C2(O)CCCCC2)cc1)c1ccc(C(=O)C2(O)CCCCC2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.35
SLC6A2 P23975 6/20 0.34
SLC6A4 P31645 6/20 0.34
SLC6A3 Q01959 6/20 0.34
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
LMNA P02545 1/20 0.33
CNR1 P21554 1/20 0.33
HTR2A P28223 1/20 0.33
HRH1 P35367 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
KDM4E B2RXH2 2/20 0.33
TSHR P16473 2/20 0.33
PABPC1 P11940 1/20 0.33
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10082675 0.82 ADORA3 (0.35) SLC6A2SLC6A4SLC6A3LMNACNR1
SCHEMBL4468889 0.81 SMN1; SMN2 (0.46) ALDH1A1LMNAKDM4EMAPTCYP2C9
SCHEMBL4418777 0.79 RXRA (0.41) SLC6A2SLC6A4SLC6A3LMNACNR1
SCHEMBL28505006 0.79 RAB9A (0.41) ALDH1A1LMNAMAPTCYP2C9HPGD
SCHEMBL13431254 0.76 NPSR1 (0.41) ALDH1A1TSHRMAPTKMT2A
SCHEMBL3792897 0.76 FASN (0.34) PKMALDH1A1KDM4EMAPTHPGD
SCHEMBL28669997 0.76 CES2 (0.52) ALDH1A1KDM4ETSHRMAPTHPGD
SCHEMBL256587 0.75 ALDH1A1 (0.45) PKMSLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL6696391 0.75 SRD5A2 (0.39) PKMALDH1A1LMNAESR1ESR2
SCHEMBL10943813 0.75 CES2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411359-B1 NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS BASF SE (DE) 2017-02-01 EP disclosed
US-20120029107-A1 NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS BASF SE (DE) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029107-A1 NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS CCNA1, CCNT1, TET1 PKM 3890/4885SLC6A2 4317/4885SLC6A4 4219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.